title: Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone.
authors.forename: G F
authors.initials: GF
authors.lastname: Busatto
authors.forename: L S
authors.initials: LS
authors.lastname: Pilowsky
authors.forename: P J
authors.initials: PJ
authors.lastname: Ell
authors.forename: D C
authors.initials: DC
authors.lastname: Costa
authors.forename: N P
authors.initials: NP
authors.lastname: Verhoeff
authors.forename: R W
authors.initials: RW
authors.lastname: Kerwin
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001549:Benzamides / Q000493:pharmacokinetics; D001921:Brain / Q000000981:diagnostic imaging / Q000187:drug effects*; D001931:Brain Mapping; D003287:Contrast Media; D065127:Dopamine D2 Receptor Antagonists; D006801:Humans; D007457:Iodine Radioisotopes; D007555:Isoxazoles / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D010880:Piperidines / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011759:Pyrrolidines / Q000493:pharmacokinetics; D017448:Receptors, Dopamine D2 / Q000502:physiology; D018967:Risperidone; D012559:Schizophrenia / Q000000981:diagnostic imaging / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D014150:Antipsychotic Agents; D001549:Benzamides; D003287:Contrast Media; D065127:Dopamine D2 Receptor Antagonists; D007457:Iodine Radioisotopes; D007555:Isoxazoles; D010880:Piperidines; D011759:Pyrrolidines; D017448:Receptors, Dopamine D2; C055743:3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide; D018967:Risperidone